Price
CHART BY
Historical dividends and forecast
Roche Hldg has so far distributed $10.82 in 2024. The next dividend will be paid on 18.03.2025
$4.526
CHART BY
Frequently asked questions
What is Roche Hldg's market capitalization?
The market capitalization of Roche Hldg is $231.65B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Roche Hldg's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Roche Hldg is 19.61. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Roche Hldg?
Roche Hldg's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $14.83. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Roche Hldg's stock?
Currently, 22 analysts cover Roche Hldg's stock, with a consensus target price of $335.91. Analyst ratings provide insights into the stock's expected performance.
What is Roche Hldg's revenue over the trailing twelve months?
Over the trailing twelve months, Roche Hldg reported a revenue of $65.43B.
What is the EBITDA for Roche Hldg?
Roche Hldg's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $22.09B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Roche Hldg?
Roche Hldg has a free cash flow of $13.00B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Roche Hldg have, and what sector and industry does it belong to?
Roche Hldg employs approximately 103,605 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
What is the free float of Roche Hldg's shares?
The free float of Roche Hldg is 29.02M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $231.65B
- EPS (TTM)
- $14.83
- Free Float
- 29.02M
- P/E ratio (TTM)
- 19.61
- Revenue (TTM)
- $65.43B
- EBITDA (TTM)
- $22.09B
- Free Cashflow (TTM)
- $13.00B
Pricing
- 1D span
- $291.57$296.08
- 52W span
- $253.76$365.30
Analyst Ratings
The price target is $335.91 and the stock is covered by 22 analysts.
Buy
9
Hold
9
Sell
4
Information
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
- Employees
- 103,605
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- CH0012032113